|
Report No. : |
304768 |
|
Report Date : |
30.01.2015 |
IDENTIFICATION DETAILS
|
Name : |
VIAN-SAGA (HONG KONG) LTD. |
|
|
|
|
Registered Office : |
C/o FS Account Ltd. Room A1, 9/F., Silvercorp
International Tower, 707-713 Nathan Road, Mongkok, Kowloon |
|
|
|
|
Country : |
Hong Kong |
|
|
|
|
Date of Incorporation : |
26.02.2009 |
|
|
|
|
Com. Reg. No.: |
50321236 |
|
|
|
|
Legal Form : |
Private Limited Liability |
|
|
|
|
Line of Business : |
Not available [We tried to confirm / obtain the detailed activity but the same is
not available from any sources] |
|
|
|
|
No. of Employee : |
No employees in Hong Kong. NOTE: It is to be noted that the
company does not have its own operating office in Hong Kong. The company uses
the address of its secretariat as its correspondence address only. Subject
operates from some other country and does not have a base in Hong Kong. Such
companies are registered in Hong Kong just to tax benefit purpose and due to
the strict privacy laws prevailing in the country. In such cases, the
companies are not required to have any employees in Hong Kong nor do have an
office there. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
Status : |
Unknown |
|
|
|
|
Payment Behaviour : |
-- |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2014
|
Country Name |
Previous Rating (30.06.2014) |
Current Rating (30.09.2014) |
|
Hong Kong |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
HONG KONG - ECONOMIC OVERVIEW
Hong Kong has a free market economy, highly dependent on international trade and finance - the value of goods and services trade, including the sizable share of re-exports, is about four times GDP. Hong Kong has no tariffs on imported goods, and it levies excise duties on only four commodities, whether imported or produced locally: hard alcohol, tobacco, hydrocarbon oil, and methyl alcohol. There are no quotas or dumping laws. Hong Kong's open economy left it exposed to the global economic slowdown that began in 2008. Although increasing integration with China, through trade, tourism, and financial links, helped it to make an initial recovery more quickly than many observers anticipated, its continued reliance on foreign trade and investment leaves it vulnerable to renewed global financial market volatility or a slowdown in the global economy. The Hong Kong government is promoting the Special Administrative Region (SAR) as the site for Chinese renminbi (RMB) internationalization. Hong Kong residents are allowed to establish RMB-denominated savings accounts; RMB-denominated corporate and Chinese government bonds have been issued in Hong Kong; and RMB trade settlement is allowed. The territory far exceeded the RMB conversion quota set by Beijing for trade settlements in 2010 due to the growth of earnings from exports to the mainland. RMB deposits grew to roughly 12% of total system deposits in Hong Kong by the end of 2013. The government is pursuing efforts to introduce additional use of RMB in Hong Kong financial markets and is seeking to expand the RMB quota. The mainland has long been Hong Kong's largest trading partner, accounting for about half of Hong Kong's total trade by value. Hong Kong's natural resources are limited, and food and raw materials must be imported. As a result of China's easing of travel restrictions, the number of mainland tourists to the territory has surged from 4.5 million in 2001 to 34.9 million in 2012, outnumbering visitors from all other countries combined. Hong Kong has also established itself as the premier stock market for Chinese firms seeking to list abroad. In 2012 mainland Chinese companies constituted about 46.6% of the firms listed on the Hong Kong Stock Exchange and accounted for about 57.4% of the Exchange's market capitalization. During the past decade, as Hong Kong's manufacturing industry moved to the mainland, its service industry has grown rapidly. Credit expansion and tight housing supply conditions have caused Hong Kong property prices to rise rapidly; consumer prices increased by more than 4% in 2013. Lower and middle income segments of the population are increasingly unable to afford adequate housing. Hong Kong continues to link its currency closely to the US dollar, maintaining an arrangement established in 1983. In 2013, Hong Kong and China signed new agreements under the Closer Economic Partnership Agreement, adopted in 2003 to forge closer ties between Hong Kong and the mainland. The new measures, effective from January 2014, cover services and trade facilitation, and will improve access to the mainland's service sector for Hong Kong-based companies.
|
Source
: CIA |
Formerly located at:
C/o Hongkong Chinaflyhk Secretary Service Ltd.
Room 1202, 12/F., Tung Chun Commercial Centre,
438-444 Shanghai Street, Kowloon,
Hong Kong.
VIAN-SAGA (HONG
KONG) LTD.
ADDRESS:
Registered
Office:-
C/o FS Account Ltd.
Room A1, 9/F., Silvercorp International Tower,
707-713 Nathan Road, Mongkok, Kowloon, Hong Kong.
Beijing Vian-Saga Biological Technology Ltd.
Room 906, Zhongcheng Group Building, 9 Xibinhe
Roa,d Dingcheng District, Beijing, China.
[Tel: 86-10-8411
8493, 8411 8494, 5618 7586
Fax: 86-10-8411
8494
E-mail: viansaga@yahoo.com.cn
vs8686@vian-saga.com]
50321236
1309642
26th February, 2009.
Nominal Share Capital: HK$10,000.00 (Divided into 10,000 shares of
HK$1.00 each)
Issued Share Capital: HK$10,000.00
(As per registry dated 26-02-2014)
|
Name |
|
No. of shares |
|
GAO Peng |
|
5,500 |
|
ZHANG Wei |
|
4,500 |
|
|
|
–––––– |
|
|
Total: |
10,000 ===== |
(As per registry dated 26-02-2014)
|
Name (Nationality) |
Address |
|
ZHANG Wei |
Room 906,
Zhongcheng Group Building, No. 9 Andingmen, Beijing, China. |
|
GAO Peng |
Room 906, Zhongcheng
Group Building, No. 9 Andingmen, Beijing, China. |
(As per registry dated 26-02-2014)
|
Name |
Address |
Co. No. |
|
FS Account Ltd. |
Room A, 9/F., Silvercorp International
Tower, 707-713 Nathan Road, Mongkok, Kowloon, Hong Kong. |
1268512 |
The subject was incorporated on 26th February, 2009 as a private limited
liability company under the Hong Kong Companies Ordinance.
Formerly the subject was located at “c/o Hongkong Chinaflyhk Secretary
Service Ltd., Room 1202, 12/F., Tung Chun Commercial Centre, 438‑444 Shanghai
Street, Kowloon, Hong Kong”, moved to the present address in February 2013 as
it has changed its commercial service provider since then.
Apart from these, neither material
change nor amendment has been ever traced and noted.
Having issued 10,000 ordinary shares of HK$1.00 each, Vian-Saga
(Hong Kong) Ltd. is jointly owned by Mr. Gao Peng, holding 55% interests;
and Mr. Zhang Wei, holding 45%. Being
China merchants, they are China passport holders and do not have the right to
reside in Hong Kong permanently. Their
registered addresses are in Beijing, China.
They are also directors of the subject.
The subject does not have its own operating office. Its registered office is in a commercial
service firm located at “Room A1, 9/F., Silvercorp International Tower, 707-713
Nathan Road, Mongkok, Kowloon, Hong Kong” known as “FS Account Ltd.” which is
handling its correspondences and documents.
FS Account Ltd. is also the corporate secretary of the subject. The “1” of “Room A1” is the file number of
the subject in the secretarial company.
The subject has no employees in Hong Kong.
The subject is an associated company of Beijing Vian-Saga Biological
Technology Ltd. [Beijing Vian-Saga] which is a China-based company. The registered address of the shareholders of
the subject is the head office of Beijing Vian-Saga.
Beijing Vian-Saga is trading in all kinds of biological products and
medical instruments. The subject trades
in the same commodities.
The subject and Beijing Vian-Saga are the agent of the following
companies:
Bayer, Roche, Germany;
Biochrom GmbH, Germany;
Cell Culture Technologies LLC, Switzerland;
Minerva Biolabs GmbH, Germany; &
Seramun Diagnostica GmbH, Germany.
Beijing Vian-Saga has got a licence to sell pharmaceuticals issued by
Beijing Food & Drug Administration of the PRC.
Zhang Wei is also the legal representative of Beijing Vian-Saga while
Gao Peng is the product quality controller of the company.
The business of Beijing Vian-Saga is rather active in China.
The products of Beijing Vian-Saga are marketed in China, re-exported to
Japan, the other Asian countries, Europe, etc.
The subject’s business in Hong Kong is not active. History in Hong Kong is about six years.
Since the subject does not
have its own operating office and has no employees in Hong Kong, consider it
good for business engagements on L/C basis.
NOTE:
It is to be noted that the
company does not have its own operating office in Hong Kong. The company uses
the address of its secretariat as its correspondence address only. Subject
operates from some other country and does not have a base in Hong Kong. Such
companies are registered in Hong Kong just to tax benefit purpose and due to
the strict privacy laws prevailing in the country. In such cases, the companies
are not required to have any employees in Hong Kong nor do have an office
there.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 61.50 |
|
|
1 |
Rs. 93.12 |
|
Euro |
1 |
Rs. 69.33 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
ASH |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.